What is THINKMD?
Founded in 2014 by a team of pediatricians, THINKMD operates at the intersection of public health and advanced software engineering. The company provides a sophisticated clinical intelligence platform that functions both online and offline, enabling users with varying levels of training to perform medically validated assessments. By digitizing clinical decision-making, the platform not only identifies patient acuity and potential illnesses but also facilitates critical population health monitoring and disease surveillance. This dual-purpose approach—improving individual patient outcomes while providing actionable data for health organizations—establishes THINKMD as a vital infrastructure provider for global health initiatives, including partnerships with major NGOs and international development agencies.
How much funding has THINKMD raised?
THINKMD has raised a total of $6.3M across 2 funding rounds:
Grant
$2.3M
Unspecified
$4M
Grant (2021): $2.3M with participation from Bill & Melinda Gates Foundation
Unspecified (2021): $4M, investors not publicly disclosed
Key Investors in THINKMD
Bill & Melinda Gates Foundation
A global philanthropic organization dedicated to reducing extreme poverty and improving healthcare outcomes through strategic grants and technology development support.
Undisclosed Investor
An institutional partner providing strategic backing to support the scaling of clinical intelligence platforms.
What's next for THINKMD?
With the recent infusion of capital, THINKMD is poised to accelerate its strategic roadmap, focusing on the expansion of its diagnostic algorithms and the integration of its platform into broader public health ecosystems. The company is expected to prioritize the scaling of its surveillance dashboards, which provide real-time insights into disease trends, thereby enhancing the capacity of healthcare systems to respond to emerging threats. As the firm moves beyond its initial development phase, the focus will likely shift toward deepening its footprint in low and middle-income countries, where the demand for scalable, AI-powered clinical support remains acute. By continuing to refine its data analytics capabilities, THINKMD is well-positioned to lead the next wave of innovation in global healthcare delivery and management.
See full THINKMD company page
